ARTICLE | Company News
Shire CEO Russell to retire in 2013
October 26, 2012 12:59 AM UTC
Shire plc (LSE:SHP; NASDAQ:SHPG) reported 3Q12 results on Thursday and said CEO Angus Russell will retire, effective April 30, 2013. He will be succeeded by Flemming Ornskov , chief marketing officer and global head of strategic marketing for general and specialty medicine at Bayer AG (Xetra:BAYN).
Shire also announced a deal with Igan Biosciences Inc. (Boston, Mass.) for exclusive, worldwide rights to Igan's preclinical immunoglobulin A (IgA) protease to treat IgA nephropathy, a rare kidney disorder. Igan declined to provide details, while Shire could not be reached for comment in time for publication. ...